List view / Grid view

Dr Céline Vallot (Group Leader at Institut Curie and Co-Founder of One Biosciences)

 

news

€15M-backed tech targets tumour complexity

Paris-based One Biosciences, a precision oncology biotech company, has raised…

23 July 2025 | By

Paris-based One Biosciences, a precision oncology biotech company, has raised €15 million in Series A financing to accelerate the development of its AI-powered single-cell tumour profiling platform.